Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the outcome of the initial phase of Moderna's mRNA norovirus vaccine trial in the UK by October 2025?
Successful with strong immune response • 25%
Moderate success • 25%
No significant effect • 25%
Trial halted • 25%
Official NHS or Moderna press release or peer-reviewed publication detailing trial outcomes
NHS Seeks Volunteers for World's First Norovirus Vaccine Trial to Prevent Thousands of Hospitalizations
Oct 23, 2024, 07:58 AM
The UK's National Health Service (NHS) is set to trial the world's first mRNA vaccine against norovirus, commonly known as the winter vomiting bug. The vaccine, developed by Moderna, aims to immunize people against the highly contagious virus, which is linked to around 12,000 hospital admissions in the UK each year. British volunteers are being sought to participate in the innovative trial, which will open across the UK, including at the Royal Victoria Infirmary (RVI), over the next two weeks. Initial results have shown that the jab creates a "strong immune response," and experts believe it could prevent thousands of hospitalizations annually and ease pressure on the NHS during winter. If successful, the vaccine could be available as soon as 2026.
View original story
Successful efficacy • 25%
Partial efficacy • 25%
No efficacy • 25%
Trial discontinued • 25%
Highly effective • 25%
Moderately effective • 25%
Slightly effective • 25%
Ineffective • 25%
Yes • 50%
No • 50%
Effective • 25%
Moderately Effective • 25%
Ineffective • 25%
Halted • 25%
Yes • 50%
No • 50%
Successful with no major side effects • 25%
Successful with some side effects • 25%
Unsuccessful • 25%
Inconclusive • 25%
Yes • 50%
No • 50%
Successful • 25%
Partially successful • 25%
Unsuccessful • 25%
No results announced • 25%
UK MHRA • 25%
US FDA • 25%
European Medicines Agency • 25%
Other • 25%
No • 50%
Yes • 50%
Children under 12 • 25%
All age groups • 25%
Elderly 65+ • 25%
Adults 18-65 • 25%